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Abstract 
Background: Hemodynamic instability is common during emergence from anesthesia which predisposes patients to 
development of different side effects. The primary purpose of the present study is to evaluate the effect of Remifentanil 
and Alfentanil on the hemodynamic profiles during and after extubation. 
Methods: Ninety-nine patients aged 20-50 years undergoing minor orthopedic surgery under general anesthesia were 
randomly allocated into control, Remifentanil and Alfentanil groups. Before extubation patients received Remifentanil 
(1 µg/kg), or Alfentanil (10 µg/kg) or 5 mL of Saline as a placebo based on their group. Baseline heart rate (HR), mean 
arterial pressure (MAP) plus systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded and 
documented again on extubation, and 1, 3 and 5 minutes after extubation. Cough status before and after extubation was 
recorded. 
Results: The basic characteristics of participants in all the three groups were similar. The rise in SBP on extubation in 
the placebo group was statistically significant compared to the Alfentanil (p=0.01) and the Remifentanil (p<0.001) 
groups. Mean arterial pressure decreased during the extubation in group R (97.0±13 mmHg) in contrast to other two 
groups (A=101.9±13 mmHg, P=101.4±13 mmHg). Heart rate increased in group A and P contrary to group R on 
extubation.  
Conclusion: Remifentanil (1µg/kg) and Alfentanil (10µg/kg) attenuate the rise in SBP on extubation but no significant 
changes were seen between these two drugs  
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Introduction 
During emergence of general anesthesia and in the 
post-extubation period, many adverse reactions such as 
hemodynamic changes and coughing can be evoked. 
Some of them may lead to surgical site bleeding and 
increasing intracranial pressure (1,2). In addition in 
some groups of patients such as those with ischemic 
heart disease or hypertension, these hemodynamic 
changes can lead to irreversible complications. 
Therefore, it is of great importance to use a technique 
to prevent these adverse effects and their consequences. 
Various techniques such as deep removal of tracheal 
tube, intravenous administration of opioids, beta 
blockers or Lidocaine prior to the emergence, and 
filling the cuff of endotracheal tube with Lidocaine or 
Sodium  bicarbonate have been used to prevent adverse 
reaction of emergence from anesthesia, however, all of 
them demonstrated some limitations and the result were 
not consistent (3-7).  
Remifentanil and Alfentanil are ultra-short acting 
opioid which has a short context sensitive half time. 
Some previous works have assessed the efficacy of this 
drug on adverse reaction of emergence of anesthesia 
(7,8). 
The primary purpose of the present study is to 
evaluate the effect of Remifentanil and Alfentanil on 
the hemodynamic profile during and after extubation 
plus study its effect on prevention of post-extubation 
coughing. 
Materials and Methods 
The protocol was approved by the Institutional 
Ethics Committee and informed written form of consent 
was obtained from all patients. In this randomized, 
double-blind placebo-controlled clinical trial 99 
subjects were randomly selected from patients enrolled 
for elective orthopedic surgery under general anesthesia 
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over a period of 12 months. 
Adults of either sex aged between 20 and 50 years 
compliant with American Society of Anesthesiologist 
physical status (ASA) I and II, elected for minor 
orthopedic surgery lasting less than two hours included 
in the study. 
The exclusion criteria consisted of any history of 
upper respiratory tract hyper reactivity, asthma or any 
other respiratory related diseases, gastro-esophageal 
reflux, previous laryngeal or tracheal surgery or 
pathology, and patients who were under treatment with 
sedatives, antitussives, or angiotensin converting 
enzyme inhibitors. Smokers and addicts (including 
opioids and benzodiazepines), were also excluded from 
the study. 
Prior to general anesthesia all the required drugs 
were prepared by an anesthetist who was not involved 
in the administration or observation of the patient; thus, 
both the anesthesiologist and the patients were blinded 
to group assignment. Patients were selected using a 
computer-generated randomization list and were 
randomly assigned into three groups, control (P group, 
n=33), Remifentanil (R group, n=33), and Alfentanil 
group (A group, n=33). 
On arrival in operating room, all patients were 
monitored with an electrocardiogram (ECG), 
noninvasive blood pressure and pulse oximetry. An 18-
gauge cannula was inserted and lactated ringer solution 
7 ml.kg-1 was administered. Anesthesia was induced 
with 5 mg.kg-1 Sodium Thiopental, 0.05 mg.kg-1 
Midazolam, and 3 µg.kg-1 Fentanyl; endotracheal 
intubation was facilitated with 0.5 mg.kg-1 Atracurium. 
After tracheal intubation, anesthesia was maintained by 
Isofluran and N2O (50%); 0.2 mg.kg-1 Atracurium and 
1µg.kg-1 Fentanyl were administered half hourly. 
Ventilation was adjusted to maintain normocapnia 
(end-tidal carbon dioxide partial pressure 4.7-5.3 kPa). 
At the beginning of the skin sutures, drugs 
administration was stopped and neuromuscular block 
was antagonized by intravenous administration of 2.5 
mg of Neostigmine along with 1.25 mg Atropine. Then, 
the patients in group R received Remifentanil (1 µg/kg), 
patients in group A received Alfentanil (10 µg/kg), and 
patients in group P received saline as a placebo, all of 
drugs were prepared into the 5 mL volume. 
Baseline heart rate (HR), mean arterial pressure 
(MAP) plus systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) were recorded. The 
neuromuscular blockade was checked using a nerve 
stimulator for adequacy of reversing of Atracurium 
effect when second or third responses to train of four 
stimulation was observed. Patients were considered 
awake when they opened their eyes on demand or after 
gentle tactile stimulation. When patients were found 
awake and tactile double burst stimulation monitoring 
demonstrated ratio higher than 50%, tracheal tube was 
removed. Variables recorded at the baseline were noted 
again on extubation, and 1, 3, and 5 minutes after 
extubation. 
Cough was defined as an abrupt noisily expulsion of 
air from the lungs plus a strong contraction of the 
abdomen. A trained investigator recorded the incidence 
of coughing before and after extubation. Grading of 
response of patients during extubation was assessed by 
a 3 point scale (mild cough=1-2 coughs, moderate 
coughs=3-5 coughs, severe coughs=sustained (>5)). 
Statistical analysis were performed using SPSS for 
windows (version 13.5; SPSS Inc., Chicago, IL, USA). 
Normal distribution of data was evaluated and 
confirmed by Kolmogorov-Smirnov test. For statistical 
analysis of demographic data and comparison of 
different groups one way ANOVA was used. Fischer’s 
exact or Chi-square tests were used for analysis of 
categorical data. HR and MAP, DBP, SBP were 
analyzed by repeated measures analysis of variances. 
Two tailed p-value<0.05 was considered statistically 
significant. 
Results 
Ninety nine patients met the inclusion criteria for 
this study. Thirty three patients were in the control 
group (C group, male (M)=16, female (F)=17) who 
received placebo and 33 in each of the other two groups 
who received Remifentanil (R group, M=19, F=14) or 
Alfentanil (A group, M=15, F=18) prior to extubation. 
The basic characteristics of the participants were 
similar in all three groups (Table 1). 
Table 1. Basic characteristics and baseline parameters of the participants. 
Variables Remifentanil Group 
Alfentanil 
Group 
Control 
Group 
Age (years) 39.2±6.7 39.8±7.3 39.7±6.1 
Weight (Kg) 69.3±12.2 70.4±9.8 69.4±9.7
Duration of the surgery (minutes) 110.9±34 101.1±40 103.3±35
Duration of anesthesia (minutes) 137.1±34 131.9±43 127.3±38
Baseline Systolic blood pressure 126.4±19 125.3±17 128.0±14
Baseline Diastolic blood Pressure 84.2±16 85.4±14 84.2±12
Baseline Mean arterial pressure 98.3±17 98.7±14 98.8±12
Baseline Heart rate 77.9±14 82.6±12 81.3±12 
* Data presented as mean ±SD
Remifentanil vs Alfentanil on extubation emergence hemodynamic profiles 
Systolic and diastolic blood pressure 
In the placebo group, systolic blood pressure "on 
extubation" (140.1±14 mmHg) was significantly higher 
compared to the Alfentanil (130.4±16 mmHg, p=0.01) 
and the Remifentanil group (126.2±13 mmHg, 
p<0.001). Post-hoc Tukey test showed that there was no 
significant difference between groups A and R. 
On the "first minute after extubation" the same trend 
was observed (139.4±13 in placebo group, 130.3±16 in 
Alfentanil group and 127.3±14 in Remifentanil group, 
p=0.003). Systolic blood pressure three minutes 
following extubation in group R (127.7±15 mmHg) was 
less than group P (135.8±1 mmHg) which was 
statistically significant (p=0.02). SBP in group A 
(129.2±16 mmHg) was not statistically different 
(p=0.058) compared to placebo group on the same 
period of time. 
Five minutes after extubation, there was no 
statistically significant differences observed in the SBP 
of the patients in the three groups (A=129.4±16, 
R=127.1±15, P=131.7±14 mmHg). Although no 
statistically significant differences was observed in 
DBP in groups P (93.7±14 mmHg) and A (87.6±13 
mmHg) during the extubation period, DBP recorded 
during the extubation time in  group R (82.5±13 
mmHg) was significantly lower compared to group P 
(p=0.004). Almost the same tendency as SBP was 
observed in the diastolic blood pressure throughout the 
study. 
Mean arterial pressure and heart rate 
Mean arterial pressure decreased on extubation in 
Group R (97.0±13 mmHg) in contrast to the other two 
groups (A=101.9±13 mmHg, P=101.4±13 mmHg). 
There was no statistically difference in between the 
three groups 1, 3, and 5 minutes after extubation. 
On extubation heart rate increased significantly in 
groups A and P (A=94.2±14 b/min, P=90.4±14 b/min), 
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in contrast to group R (83.9±12 b/min, p=0.007). After 
extubation alterations in the heart rate were not 
statistically different in between the three groups. 
Cough 
The incidence of coughing before extubation for all 
the patients was 33% (Group A=7%, Group R=14%, 
Group P=12%) and after extubation the number 
decreased to %15 (Group A=5%, Group R=4%, Group 
P=6%) but there was no statistically difference in 
between the groups before or after the extubation. 
According to the 3-point grading scale of the cough, 21 
patients had a decrease and 3 patients had an increase 
in cough’s grading after extubation. In Group R, 30.3% 
of the patients had a decrease in cough grades after 
extubation. 
Discussion 
In this study extubation hemodynamic profiles of 
the patients receiving a bolus dose of either 
Remifentanil, Alfentanil or placebo prior to post-
extubation were observed. This study demonstrated that 
administration of a bolus dose of Remifentanil (1µg/kg) 
or Alfentanil (10µg/kg) does attenuate the rise in SBP 
during the extubation period but no significant changes 
were seen between these two drugs. We also showed 
that a bolus dose of Remifentanil (1µg/kg) could make 
the hemodynamic response to extubation smooth, by 
decreasing the heart rate and decreasing the rise in MAP 
during extubation compared to Alfentanil and placebo, 
but these effects did not persist after extubation. The 
incidence of coughing during and after extubation was 
quite the same in all the three groups, although patients 
whom received Alfentanil had the lowest frequency of 
coughing before extubation and patients with a pre-
extubation bolus dose of Remifentanil had the lowest 
incidence of coughing after the extubation. 
Rapid emergence from extubation with reliable 
return of airway reflexes is of great importance but 
Table 2. Hemodynamic changes during extubation in patients receiving a bolus dose of Remifentanil or Alfentanil or placebo. 
Variables Groups Baseline On Extubation 1st minute 3rd Minute 5th Minute 
Heart rate (b/min) Remifentanil 
Alfentanil 
Placebo 
p-value
7.9±14
82.6±12 
81.3±12 
0.319 
83.9±12 
94.2±14 
90.4±14 
0.010 
85.0±11 
92.5±13 
91.0±16 
0.059 
82.7±12 
89.1±12 
90.1±17 
0.060 
81.8±12 
88.0±12 
86.3±14 
0.122 
Systolic Blood Pressure (mmHg) Remifentanil 
Alfentanil 
Placebo 
p-value
126.4±19 
125.3±17 
128.0±14 
0.804 
126.2±13 
130.4±16 
140.1±14 
0.001 
127.3±14 
130.3±16 
139.4±13 
0.003 
127.7±15 
129.2±16 
135.8±11 
0.047 
127.1±15 
129.4±16 
131.7±14 
0.462 
Diastolic Blood Pressure (mmHg) Remifentanil 
Alfentanil 
Placebo 
p-value
84.2±16 
85.4±14 
84.2±12 
0.918 
82.5±13 
87.6±13 
93.7±14 
0.004 
84.0±15 
86.9±12 
89.4±13 
0.268 
82.2±5.0 
85.8±11 
84.4±10 
0.488 
81.9±14 
84.7±10 
83.5±11 
0.613 
Mean Arterial Pressure (mmHg) Remifentanil 
Alfentanil 
Placebo 
p-value
98.3±17 
98.7±14 
98.8±12 
0.987 
97.0±13 
101.9±13 
101.4±13 
0.001 
98.5±14 
101.4±12 
106.0±12 
0.050 
97.4±14 
100.3±11 
101.6±10 
0.351 
96.9±14 
99.6±10 
99.6±11 
0.593 
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conducting not only a rapid but smooth emergence with 
the least hemodynamic changes is always a great 
challenge to anesthesiologist. 
Remifentanil, is a short-acting μ-receptor opioid 
agonist which undergoes widespread extrahepatic 
metabolism by blood and tissue nonspecific esterases, 
resulting in an extremely rapid clearance of 
approximately 3 L/min (180 L/h) (8). 
It has been shown that a bolus dose of Alfentanil can 
be helpful in modifying the response to intubation (10). 
In one study, it has been demonstrated that 
Remifentanil treated patients have more stable 
hemodynamic profiles intra-operatively compared to 
Fentanyl treated patients but questioned this constancy 
during the extubation period (11). Maguire et al also 
studied the effect of Remifentanil and Alfentanil on 
intubation and concluded that both of these drugs 
attenuate the intubation profiles similarly (12). In 
studies mentioned above less attention is paid to the 
extubation profiles which is the main goal of the present 
study. 
The study of intravenous Alfentanil on airway 
circulatory reflexes during extubation has shown a 
decrease resulting an enhanced extubation (13,15). 
Earlier studies show that maintaining an infusion of 
Remifentanil throughout the operation could help 
smooth the emergence from extubation by reducing 
cough (14,16). 
Although previously Remifentanil's effect on 
hemodynamic changes intra operatively and on 
extubation profiles has been studied but there is a lack 
of data on comparison of this opioid with other opioids 
on cardiovascular parameters (17). 
The question that whether a bolus dose of 
Remifentanil is as effective as the infusion of this drug 
and adjustment of the dosage of the drug for the best 
result is still unanswered. Remifentanil's effects on 
extubation profiles in comparison to other opioids such 
as Alfentanil need more attention because achieving a 
smoothly controlled extubation should be in the interest 
of every anesthesiologist. 
Conclusion 
This study showed that Remifentanil and Alfentanil 
not decreases the cough incidence after extubation and 
on the whole a greater stability in the hemodynamic 
profiles was observed with Remifentanil compared to 
Alfentanil. 
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